PAI-1 Levels in People with Hair Loss Conditions
The Case of a Late Bleeder Plasminogen Activator Inhibitor 1 Deficiency
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory | Molecular Psychiatry
Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection | Scientific Reports
Plasminogen Activator Inhibitor-1 Signaling Pathway - Creative Diagnostics
IJMS | Free Full-Text | PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
Role of PAI-1 in fibrinolytic system. | Download Scientific Diagram
Frontiers | Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
PAI-1 inhibitor: RS5614 | Renascience
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
Plasminogen Activator Inhibitor Type 1 Deficiency
Schematic representation of PAI-1 action. PAI-1 not only inhibits local... | Download Scientific Diagram
PAI-1 Assays
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
Prothrombotic mechanisms of tumor cells. PAI-1: plasminogen activator... | Download Scientific Diagram
Plasminogen activator inhibitor-1 - Wikipedia
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship | Diabetology & Metabolic Syndrome | Full Text
uPA‐PAI‐1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils | EMBO Molecular Medicine
Journal of Cellular Biochemistry | Wiley Online Library
Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells - ScienceDirect
Proposed roles of local and circulating plasminogen activator inhibitor... | Download Scientific Diagram
PAI-1: An Integrator of Cell Signaling and Migration
Plasminogen Activator Inhibitor (PAI) - YouTube
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease | NEJM
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
